Senores Pharmaceuticals Ltd vs Sigachi Industries Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 04, 2026

Key Highlights

The Latest Trading Price of Senores Pharmaceuticals Ltd is ₹ 899.7 as of 04 May 11:21 . The P/E Ratio of Senores Pharmaceuticals Ltd changed from 45 on March 2025 to 45 on March 2025 . This represents a CAGR of 0.00% over 1 yearsThe P/E Ratio of Sigachi Industries Ltd changed from 22.2 on March 2022 to 19.3 on March 2025 . This represents a CAGR of -3.44% over 4 years The Market Cap of Senores Pharmaceuticals Ltd changed from ₹ 2637 crore on March 2025 to ₹ 2637 crore on March 2025 . This represents a CAGR of 0.00% over 1 yearsThe Market Cap of Sigachi Industries Ltd changed from ₹ 888.92 crore on March 2022 to ₹ 1342 crore on March 2025 . This represents a CAGR of 10.85% over 4 years The revenue of Senores Pharmaceuticals Ltd for the Dec '25 is ₹ 178.34 crore as compare to the Sep '25 revenue of ₹ 167.17 crore. This represent the growth of 6.68% The revenue of Sigachi Industries Ltd for the Dec '25 is ₹ 117.68 crore as compare to the Sep '25 revenue of ₹ 117.63 crore. This represent the growth of 0.04% The ebitda of Senores Pharmaceuticals Ltd for the Dec '25 is ₹ 57.79 crore as compare to the Sep '25 ebitda of ₹ 54.92 crore. This represent the growth of 5.23% The ebitda of Sigachi Industries Ltd for the Dec '25 is ₹ 5.45 crore as compare to the Sep '25 ebitda of ₹ 14.67 crore. This represent the decline of -62.85% The net profit of Senores Pharmaceuticals Ltd changed from ₹ 10.91 crore to ₹ 33.58 crore over 7 quarters. This represents a CAGR of 90.11% The net profit of Sigachi Industries Ltd changed from ₹ 12.76 crore to ₹ -0.02 crore over 7 quarters. This represents a CAGR of NaN% The Dividend Payout of Senores Pharmaceuticals Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Sigachi Industries Ltd changed from 8.08 % on March 2022 to 8.02 % on March 2025 . This represents a CAGR of -0.19% over 4 years .

About Senores Pharmaceuticals Ltd

Senores Pharmaceuticals Limited was originally incorporated as 'Senores Pharmaceuticals Private Limited' through a Certificate of Incorporation dated December 26, 2017, issued by the Registrar of Companies, Central Registration Centre.
Thereafter, the name of the Company was changed to 'Senores Pharmaceuticals Limited' upon conversion to a Public Limited Company and a fresh Certificate of Incorporation dated September 4, 2023, was issued by the RoC to the Company. Senores Pharma is a global research driven pharmaceutical company engaged in developing and manufacturing a wide range of pharmaceutical products predominantly for Regulated Markets across various therapeutic areas and dosage forms.
The Regulated Markets business is focused on Regulated Markets of US and Canada.
The Company has adopted a strategy of identifying, developing and commercializing specialty and complex niche products in the mid-market range and received approvals for 19 ANDAs.

About Sigachi Industries Ltd

Sigachi Industries Limited was originally incorporated as 'Sigachi Chloro-Chemicals Private Limited' on 11 January, 1989.
To diversify the business activities, the name of Company was changed to 'Sigachi Industries Private Limited' on 29 March, 2012.
Subsequently, it was converted from a Private Limited to a Public Limited and the name was changed to 'Sigachi Industries Limited' on 19 December, 2019. The Company is is one of the major producer and distributor of Micro Crystalline Cellulose Powder(MCCP).
The Company currently offers 59 distinct grades of MCC through its two state-of-the-art manufacturing facilities in Hyderabad and Gujarat, with a total installed capacity of 11,880 MTPY. Apart from these, it is an industry leader in the field of Pharma Excipients, Nutra and food ingredients.

FAQs for the comparison of Senores Pharmaceuticals Ltd and Sigachi Industries Ltd

Which company has a larger market capitalization, Senores Pharmaceuticals Ltd or Sigachi Industries Ltd?

Market cap of Senores Pharmaceuticals Ltd is 4,138 Cr while Market cap of Sigachi Industries Ltd is 767 Cr

What are the key factors driving the stock performance of Senores Pharmaceuticals Ltd and Sigachi Industries Ltd?

The stock performance of Senores Pharmaceuticals Ltd and Sigachi Industries Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Senores Pharmaceuticals Ltd and Sigachi Industries Ltd?

As of May 4, 2026, the Senores Pharmaceuticals Ltd stock price is INR ₹898.7. On the other hand, Sigachi Industries Ltd stock price is INR ₹20.08.

How do dividend payouts of Senores Pharmaceuticals Ltd and Sigachi Industries Ltd compare?

To compare the dividend payouts of Senores Pharmaceuticals Ltd and Sigachi Industries Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.